| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.058 | 0.4 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |